Arriving in the field of obesity therapy, retatrutide is a unique approach. Different from many available medications, retatrutide functions as a twin agonist, at once targeting both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) binding sites. The concurrent stimulation promotes various beneficial effects, such as im… Read More